45
Participants
Start Date
September 30, 2007
Primary Completion Date
March 31, 2013
Study Completion Date
December 31, 2013
gadobenate dimeglumine (MultiHance)
The contrast agent, gadobenate dimeglumine, will be used during MR imaging for both the baseline and 1 month f/u studies.
The Johns Hopkins Hospital, Baltimore
Collaborators (1)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER
Bracco Diagnostics, Inc
INDUSTRY